Dow Announces Formation of Pfenex Inc. – A New Independent Company That Will Enable Rapid, Cost Effective Production of Recombinant Proteins
MIDLAND, Mich. & NEW YORK, December 7, 2009– The Dow Chemical Company (NYSE: DOW) today announced that it has formed a new independent company that will be known as Pfenex Inc.1 through its Dow Venture Capital group. The new company, headquartered in San Diego, California, is based on human health applications of a Dow-developed technology [...]
